Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 01/20: (ZFGN) (SYN) (CBAY) Higher; (FTNT) (AMD) (IBM) Lower (more...)

January 20, 2016 9:29 AM
Zafgen (NASDAQ: ZFGN) 35.9% HIGHER; announced positive efficacy results from the bestPWS ZAF-311 study, a pivotal, double-blind, placebo-controlled Phase 3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles